| Subscription & copyright page | 2022/10/01 | English | |
| Advisory Board and Contents | 2022/03/01 | English | |
| Subscription and copyright page | 2022/03/01 | English | |
| Every patient | 2022/04/01 | English | |
| Editorial Board and Contents | 2015/11/01 | English | |
| Editorial Board and Contents | 2018/05/01 | English | |
| Editorial Board and Contents | 2017/10/01 | English | |
| Editorial Board and Contents | 2017/11/01 | English | |
| Editorial Board and Contents | 2016/03/01 | English | |
| Editorial Board and Contents | 2016/11/01 | English | |
| Editorial Board and Contents | 2017/09/01 | English | |
| Editorial Board and Contents | 2018/06/01 | English | |
| Making Mistakes Empowers Cancer Cells | 2018/07/01 | English | |
| Editorial Board and Contents | 2017/12/01 | English | |
| Editorial Board and Contents | 2017/02/01 | English | |
| Editorial Board and Contents | 2016/07/01 | English | |
| Editorial Board and Contents | 2016/08/01 | English | |
| Editorial Board and Contents | 2016/04/01 | English | |
| José Baselga: A Vision and Roadmap for Cancer Research | 2016/10/01 | English | |
| The New Frontiers in Cancer | 2016/10/01 | English | |
| Paul Workman: Drugging the Cancer Genome | 2016/10/01 | English | |
| Jennifer Doudna: Tailoring the Genome | 2016/10/01 | English | |
| Barbara Dunn: Preventing Cancer | 2016/10/01 | English | |
| Advisory Board and Contents | 2023/06/01 | English | |
| Subscription and copyright page | 2023/06/01 | English | |
| Tumor-resident microbes: the new kids on the microenvironment block | 2024/04/01 | English | |
| Many faces, many places: delving deeper into CAF heterogeneity in NSCLC | 2024/04/01 | English | |
| KMT2C and KMT2D aberrations in breast cancer | 2024/03/01 | English | |
| Limited dsRNA editing impedes leukemia stem cells | 2024/04/01 | English | |
| Persisting cancer cells are different from bacterial persisters | 2024/03/01 | English | |